Ossiam’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-289,726
| Closed | -$23.2M | – | 422 |
|
|
2025
Q3 | $23.2M | Sell |
289,726
-28,966
| -9% | -$2.47M | 0.3% | 63 |
|
|
2025
Q2 | $29M | Buy |
318,692
+302,553
| +1,875% | +$27.6M | 0.33% | 65 |
|
|
2025
Q1 | $1.51M | Buy |
16,139
+10,705
| +197% | +$959K | 0.02% | 261 |
|
|
2024
Q4 | $494K | Sell |
5,434
-30,324
| -85% | -$2.89M | 0.01% | 457 |
|
|
2024
Q3 | $3.71M | Sell |
35,758
-894,610
| -96% | -$91.2M | 0.07% | 137 |
|
|
2024
Q2 | $90.3M | Sell |
930,368
-633,400
| -41% | -$58.4M | 1.71% | 13 |
|
|
2024
Q1 | $141M | Buy |
1,563,768
+1,229,891
| +368% | +$104M | 2.47% | 6 |
|
|
2023
Q4 | $26.6M | Buy |
333,877
+314,538
| +1,626% | +$23.6M | 0.43% | 57 |
|
|
2023
Q3 | $1.38M | Sell |
19,339
-297,152
| -94% | -$22.2M | 0.02% | 285 |
|
|
2023
Q2 | $24.4M | Sell |
316,491
-348,556
| -52% | -$27M | 0.44% | 60 |
|
|
2023
Q1 | $50M | Buy |
665,047
+638,559
| +2,411% | +$47.5M | 1.04% | 25 |
|
|
2022
Q4 | $2.09M | Buy |
26,488
+13,957
| +111% | +$1.05M | 0.05% | 196 |
|
|
2022
Q3 | $880K | Sell |
12,531
-519,751
| -98% | -$40.8M | 0.03% | 280 |
|
|
2022
Q2 | $42.7M | Buy |
532,282
+175,696
| +49% | +$13.7M | 1.28% | 21 |
|
|
2022
Q1 | $27M | Buy |
356,586
+345,577
| +3,139% | +$27.4M | 0.71% | 34 |
|
|
2021
Q4 | $940K | Buy |
11,009
+7,156
| +186% | +$559K | 0.02% | 243 |
|
|
2021
Q3 | $291K | Sell |
3,853
-89,997
| -96% | -$7.15M | 0.01% | 358 |
|
|
2021
Q2 | $7.46M | Buy |
93,850
+48,249
| +106% | +$3.95M | 0.2% | 75 |
|
|
2021
Q1 | $3.6M | Sell |
45,601
-51,476
| -53% | -$4.03M | 0.11% | 127 |
|
|
2020
Q4 | $8.3M | Buy |
97,077
+55,896
| +136% | +$4.62M | 0.29% | 75 |
|
|
2020
Q3 | $3.18M | Buy |
41,181
+23,890
| +138% | +$1.82M | 0.13% | 108 |
|
|
2020
Q2 | $1.27M | Buy |
17,291
+11,242
| +186% | +$799K | 0.08% | 151 |
|
|
2020
Q1 | $401K | Sell |
6,049
-11,692
| -66% | -$825K | 0.03% | 267 |
|
|
2019
Q4 | $1.22M | Buy |
17,741
+9,349
| +111% | +$637K | 0.09% | 127 |
|
|
2019
Q3 | $617K | Sell |
8,392
-81,429
| -91% | -$5.91M | 0.04% | 210 |
|
|
2019
Q2 | $6.44M | Buy |
89,821
+52,345
| +140% | +$3.72M | 0.5% | 44 |
|
|
2019
Q1 | $2.57M | Buy |
37,476
+12,624
| +51% | +$815K | 0.21% | 90 |
|
|
2018
Q4 | $1.48M | Buy |
+24,852
| New | +$1.55M | 0.22% | 104 |
|
Other funds holding CL
Ossiam's CL Position: Q4 2025 in Review
Ossiam sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 289,726 shares — an estimated $23.2M sold.
Ossiam first reported a position in CL in Q4 2018 and held it in 28 quarters. The position peaked at $141M in Q1 2024. 1,887 funds tracked by Wall St. Rank hold CL as of Q4 2025.
- Ossiam reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
- Ossiam sold 289,726 Colgate-Palmolive shares in Q4 2025, an estimated $23.2M.
- Ossiam first reported a position in Colgate-Palmolive in Q4 2018 and held it in 28 quarters.
- Ossiam's Colgate-Palmolive position peaked at $141M in Q1 2024.
- 1,887 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.
Based on Ossiam's 13F filing for Q4 2025, filed 13 Feb 2026.